These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

847 related articles for article (PubMed ID: 25667169)

  • 81. Developments on antibiotics for multidrug resistant bacterial Gram-negative infections.
    Voulgaris GL; Voulgari ML; Falagas ME
    Expert Rev Anti Infect Ther; 2019 Jun; 17(6):387-401. PubMed ID: 31006284
    [No Abstract]   [Full Text] [Related]  

  • 82. [Collateral damage of cephalosporins and quinolones and possibilities for control].
    Saner FH; Canbay A; Gerken G; Broelsch CE
    Med Klin (Munich); 2009 Feb; 104(2):114-8. PubMed ID: 19242662
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Progress in the Fight Against Multidrug-Resistant Bacteria? A Review of U.S. Food and Drug Administration-Approved Antibiotics, 2010-2015.
    Deak D; Outterson K; Powers JH; Kesselheim AS
    Ann Intern Med; 2016 Sep; 165(5):363-72. PubMed ID: 27239977
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Mechanism and Potential Inhibitors of GlmU: A Novel Target for Antimicrobial Drug Discovery.
    Sharma R; Khan IA
    Curr Drug Targets; 2017; 18(14):1587-1597. PubMed ID: 27138757
    [TBL] [Abstract][Full Text] [Related]  

  • 85. 10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America.
    Boucher HW; Talbot GH; Benjamin DK; Bradley J; Guidos RJ; Jones RN; Murray BE; Bonomo RA; Gilbert D;
    Clin Infect Dis; 2013 Jun; 56(12):1685-94. PubMed ID: 23599308
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Antimicrobial Resistance in ESKAPE Pathogens.
    De Oliveira DMP; Forde BM; Kidd TJ; Harris PNA; Schembri MA; Beatson SA; Paterson DL; Walker MJ
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32404435
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Siderophore Conjugates of Daptomycin are Potent Inhibitors of Carbapenem Resistant Strains of Acinetobacter baumannii.
    Ghosh M; Lin YM; Miller PA; Möllmann U; Boggess WC; Miller MJ
    ACS Infect Dis; 2018 Oct; 4(10):1529-1535. PubMed ID: 30043609
    [TBL] [Abstract][Full Text] [Related]  

  • 88. New and Emerging Antibiotics for Complicated Intra-Abdominal Infections.
    Durand CR; Alsharhan M; Willett KC
    Am J Ther; 2017; 24(6):e763-e769. PubMed ID: 26796653
    [TBL] [Abstract][Full Text] [Related]  

  • 89. C8-Linked Pyrrolobenzodiazepine Monomers with Inverted Building Blocks Show Selective Activity against Multidrug Resistant Gram-Positive Bacteria.
    Andriollo P; Hind CK; Picconi P; Nahar KS; Jamshidi S; Varsha A; Clifford M; Sutton JM; Rahman KM
    ACS Infect Dis; 2018 Feb; 4(2):158-174. PubMed ID: 29260545
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Treatment guidelines for multidrug-resistant Gram-negative microorganisms.
    Cantón R; Ruiz-Garbajosa P
    Rev Esp Quimioter; 2023 Nov; 36 Suppl 1(Suppl 1):46-51. PubMed ID: 37997871
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections.
    Villano S; Steenbergen J; Loh E
    Future Microbiol; 2016 Oct; 11():1421-1434. PubMed ID: 27539442
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Infectious Diseases Society of America's 10 × '20 Initiative (10 New Systemic Antibacterial Agents US Food and Drug Administration Approved by 2020): Is 20 × '20 a Possibility?
    Talbot GH; Jezek A; Murray BE; Jones RN; Ebright RH; Nau GJ; Rodvold KA; Newland JG; Boucher HW;
    Clin Infect Dis; 2019 Jun; 69(1):1-11. PubMed ID: 30715222
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Unlocking the bacterial membrane as a therapeutic target for next-generation antimicrobial amphiphiles.
    Mehta D; Saini V; Aggarwal B; Khan A; Bajaj A
    Mol Aspects Med; 2021 Oct; 81():100999. PubMed ID: 34325929
    [TBL] [Abstract][Full Text] [Related]  

  • 94. New antibiotics for the treatment of infections by multidrug-resistant microorganisms.
    Escolà-Vergé L; Los-Arcos I; Almirante B
    Med Clin (Barc); 2020 May; 154(9):351-357. PubMed ID: 31926653
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Recent progress in development of antibiotics against Gram-negative bacteria].
    Xu ZQ; Xu ZY
    Yao Xue Xue Bao; 2013 Jul; 48(7):993-1004. PubMed ID: 24133966
    [TBL] [Abstract][Full Text] [Related]  

  • 96. New and improved? A review of novel antibiotics for Gram-positive bacteria.
    Abbas M; Paul M; Huttner A
    Clin Microbiol Infect; 2017 Oct; 23(10):697-703. PubMed ID: 28642145
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A potent synthetic inorganic antibiotic with activity against drug-resistant pathogens.
    Hubick S; Jayaraman A; McKeen A; Reid S; Alcorn J; Stavrinides J; Sterenberg BT
    Sci Rep; 2017 Feb; 7():41999. PubMed ID: 28165020
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Resistance of Gram-Positive Bacteria to Current Antibacterial Agents and Overcoming Approaches.
    Karaman R; Jubeh B; Breijyeh Z
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32586045
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A review of the carbapenems in clinical use and clinical trials.
    Lo TS; Welch JM; Alonto AM; Vicaldo-Alonto EA
    Recent Pat Antiinfect Drug Discov; 2008 Jun; 3(2):123-31. PubMed ID: 18673125
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Characterization of Antibacterial Activities of Eastern Subterranean Termite, Reticulitermes flavipes, against Human Pathogens.
    Zeng Y; Hu XP; Suh SJ
    PLoS One; 2016; 11(9):e0162249. PubMed ID: 27611223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.